article thumbnail

The DDW Podcast: 2022 in review 

Drug Discovery World

Recombinant DNA technology and its impact on modern drug discovery . What can we learn from the genome? . What does gene-based medicine have to offer? . . Is genomic data the new frontier in drug discovery? . Sitting Down With . Catch up on the Sitting Down With podcast episodes released in 2022: .

article thumbnail

Beyond the Pill: The Rise of Biologics and the Evolution of Pharmaceutical Therapies

Cloudbyz

Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins.

Gene 73
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading innovators in gene splicing using nucleases for the pharmaceutical industry

Pharmaceutical Technology

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Gene splicing using nucleases. Nucleases are enzymes that hydrolytically cleave the phosphodiester backbone of DNA.

article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

Recombinant DNA technology and improved protein purification techniques further contributed to our understanding and explorations of drug targets. Essentially, a biological network is a connected graph of nodes that could represent diseases, genes, proteins, atoms, organs, microorganisms, drugs or ligands.